title: Caspase cleavage of the amyloid precursor protein modulates amyloid beta-protein toxicity.
abstract: The amyloid beta-protein precursor (APP) is proteolytically cleaved to generate the amyloid beta-protein (Abeta), the principal constituent of senile plaques found in Alzheimer's disease (AD). In addition, Abeta in its oligomeric and fibrillar forms have been hypothesized to induce neuronal toxicity. We and others have previously shown that APP can be cleaved by caspases at the C-terminus to generate a potentially cytotoxic peptide termed C31. Furthermore, this cleavage event and caspase activation were increased in the brains of AD, but not control, cases. In this study, we show that in cultured cells, Abeta induces caspase cleavage of APP in the C-terminus and that the subsequent generation of C31 contributes to the apoptotic cell death associated with Abeta. Interestingly, both Abeta toxicity and C31 pathway are dependent on the presence of APP. Both APP-dependent Abeta toxicity and C31-induced apoptotic cell death involve apical or initiator caspases-8 and -9. Our results suggest that Abeta-mediated toxicity initiates a cascade of events that includes caspase activation and APP cleavage. These findings link C31 generation and its potential cell death activity to Abeta cytotoxicity, the leading mechanism proposed for neuronal death in AD.
authors.affiliation: Department of Neurosciences, University of California, San Diego, La Jolla 92093, USA.
authors.forename: Daniel C
authors.initials: DC
authors.lastname: Lu
authors.forename: Salvador
authors.initials: S
authors.lastname: Soriano
authors.forename: Dale E
authors.initials: DE
authors.lastname: Bredesen
authors.forename: Edward H
authors.initials: EH
authors.lastname: Koo
mesh_terms: D019943:Amino Acid Substitution; D016229:Amyloid beta-Peptides / Q000633:toxicity*; D016564:Amyloid beta-Protein Precursor / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D020169:Caspases / Q000235:genetics / Q000378:metabolism*; D020134:Catalytic Domain / Q000235:genetics; D045744:Cell Line, Tumor; D004305:Dose-Response Relationship, Drug; D051379:Mice; D009447:Neuroblastoma / Q000188:drug therapy / Q000378:metabolism; D010446:Peptide Fragments / Q000096:biosynthesis / Q000633:toxicity*; D017434:Protein Structure, Tertiary / Q000187:drug effects / Q000502:physiology; D051381:Rats; D014162:Transfection
chemical_list: D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42); D020169:Caspases